Clinical Trial

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

Study acronym: MYCOHYPE
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To our knowledge, there is no randomized controlled trial assessing the efficacy of mycophenolate mofetil (MMF) in the treatment of HP. We aim to perform a randomized study to assess the efficacy and safety of a regimen consisting of MMF and prednisolone against a regimen consisting of prednisolone alone for treating fibrotic HP. We hypothesize that the treatment of patients with fibrotic HP with MMF and prednisolone will be more effective and safer than treatment with prednisolone alone.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-11-15; most recent amendment 2026-05-30.
Status change: Recruiting → Active, Not Recruiting 2026-05-30
Status change: Not Yet Recruiting → Recruiting 2022-11-29
Trial Details
NCT Number NCT05626387
Lead Sponsor Post Graduate Institute of Medical Education and Research, Chandigarh
Conditions Hypersensitivity Pneumonitis
Enrollment 144 participants
Start Date 2022-11-23
Primary Completion 2026-09-23 (estimated)
Study Completion 2026-10-23 (estimated)
Updated on ClinicalTrials.gov 2026-06-03